Nordic Nanovector ASA reports Q3 results

• Nordic Nanovector ASA (OTCPK:NRNVF): Q3 GAAP EPS of -NOK 1.11.
• Press Release
• Cash and cash equivalents amounted to NOK 369.5M at the end of September 2021, compared to NOK 450.1M at the end of June 2021, and NOK 294.0M at the end of December 2020.
• The company's current cash position will support its operations into H2'2022 and will enable further preparatory work on the potential Betalutin® BLA filing and planning for commercialisation to be undertaken.